Glenn W. Welling - Engaged Capital 13F Activity & Position Changes (Q4 2024)

As of Dec 31, 2024, the Engaged Capital portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 14, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2024, the filing reported:

New Buys - Chart Industries, Inc.

Increases - Evolent Health, Inc

Reductions - NCR Atleos Corporation, PRA Group, Inc., NCR Voyix Corporation

Complete Exits - BlackLine, Inc., Nevro Corp.

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q4 2024	BL BlackLine, Inc.	BlackLine, Inc.	Sell - Position Exit	-609,713	-100.0%	$0.00	-
Q4 2024	EVH Evolent Health, Inc	Evolent Health, Inc	Buy	+1,415,300	+35.5%	$60.80M	5,404,768
Q4 2024	GTLS Chart Industries, Inc.	Chart Industries, Inc.	Buy - Position Entry	+224,796	-	$42.90M	224,796
Q4 2024	NATL NCR Atleos Corporation	NCR Atleos Corporation	Sell	-802,182	-26.7%	$74.83M	2,206,041
Q4 2024	NVRO Nevro Corp.	Nevro Corp.	Sell - Position Exit	-2,442,956	-100.0%	$0.00	-
Q4 2024	PRAA PRA Group, Inc.	PRA Group, Inc.	Sell	-1,083,567	-63.6%	$12.95M	619,945
Q4 2024	VYX NCR Voyix Corporation	NCR Voyix Corporation	Sell	-1,399,996	-19.5%	$79.87M	5,771,033